Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World September 2008 Maria Burke	Something in the water Drugs have been finding their way into our water supplies for as long as they have been in use, so should we worry?
Chemistry World June 24, 2011 Hepeng Jia	Pharma pollution is out of control in China Active pharmaceutical ingredients pollution problems seem to continue even after the Chinese government increased efforts to reduce environmental pollution from drug makers.
Managed Care March 2008	Drug Caps Lower Spending, but .... These policies tend to make consumers shoulder some of the cost of prescriptions and the cost could be a barrier to medication adherence.
Reactive Reports Issue 37 David Bradley	Shipping News International shipping may be one of the largest sources of air pollutants along the Norwegian coast and in the Northern Atlantic.
Chemistry World February 14, 2013 Patrick Walter	Drugs to blame for anti-social fish Swedish scientists say that low levels of psychotherapeutic drugs can change the way fish behave and could be altering the balance of entire aquatic food webs.
Chemistry World April 24, 2009 Rebecca Trager	EPA decision threatens chemical industry Chemical facilities could face burdensome permits and pricey construction requirements following the US Environmental Protection Agency's (EPA) preliminary determination that greenhouse gas emissions endanger human health and welfare.
IndustryWeek January 20, 2010 Peter Alpern	EPA Sets Stage to Battle Climate Change The Environmental Protection Agency has signaled that it might not wait for Congress and instead move ahead with its own regulations in the coming months.
The Motley Fool April 2, 2007 Brian Lawler	A Good Week for Alexza The pharma reports positive clinical trial results. Investors, take note.
BusinessWeek October 29, 2007 Ben Elgin	The Fuzzy Math of Eco-Accolades Plaudits for lower emissions don't mean they've been cut.
Chemistry World January 22, 2015 Rebecca Trager	US methane emissions reduction effort generates sparks The White House has set a new goal of cutting methane emissions from the oil and gas sector by 40-45% by 2025.
The Motley Fool September 30, 2011 Brian Orelli	When You Need More Than Just a Low-Margin Business Teva Pharmaceuticals, arguably the largest generic-drug maker, can use economies of scale more easily than smaller companies like Watson Pharmaceuticals or Par Pharmaceutical, but it's still pushing further into branded drugs.
Chemistry World July 8, 2008 Manisha Lalloo	UK Slows Introduction of Biofuels The UK has scaled back its plans to introduce biofuels after a government-commissioned report warned that too little is known about their wider social and environmental impacts.
Chemistry World May 24, 2011 Andrew Turley	Chemical industry fears over UK emissions plans Government plans to cut UK greenhouse gas emissions risk crippling the chemical sector and thereby harming chances of moving to a low emissions future
Reason October 2004 Adrian Moore	Hydrogen Hot Air In most cases fueling cars with hydrogen would make little net difference in emissions of greenhouse gases, and in some cases would even increase them.
The Motley Fool April 21, 2009 Brian Orelli	Reworking the Broken R&D Model When it comes to drug development, it's becoming increasingly clear that competition isn't always the best thing for the industry. Collaborations will help bring drugs to the market more cheaply.
The Motley Fool January 8, 2008 Brian Orelli	Brits May Bludgeon Drug Companies The U.K.'s National Health Service delivers a shock to drugmakers; it is considering a 10% drop in the rate that it pays for drugs, to help it reach its goal of a 3% reduction in the nation's overall health-care bill.
Chemistry World January 17, 2012 Rebecca Trager	EPA Publicises Greenhouse Gas Emissions Data The US Environmental Protection Agency has for the first time released comprehensive greenhouse gas emissions data on large facilities and made them available online. But the American Chemistry Council says the new EPA data misrepresents the chemical industry's total GHG emissions.
Chemistry World May 21, 2015 Rebecca Trager	Canada sets climate target The Canadian government has set a goal of reducing the nation's greenhouse gas emissions from the oil-and-gas, natural gas-fired electricity, chemicals and nitrogen fertilizer sectors.
Chemistry World February 8, 2010 Rebecca Renner	Coming clean on emissions outsourcing Industrialized countries 'outsource' a large proportion of the carbon dioxide emissions associated with manufacturing the items they consume, according to a new study that, for the first time, details this outsourcing on a global basis.
Scientific American January 2009 Jessica Wapner	Hurdles Facing Unused Prescription Drug Repositories State-legislated programs for the donation of unused drugs have seen limited success
InternetNews October 13, 2004 Roy Mark	Report: The Internet and Drugs Don't Mix It seems an increasing number of Americans are researching drugs online, but safety fears chill buying.
Wired May 19, 2008	Inconvenient Truths: Get Ready to Rethink What It Means to Be Green It's high time for green causes to unite around the urgent need to reduce emissions of greenhouse gases.
IndustryWeek January 20, 2010 Peter Alpern	The Future of Energy Part One -- Emissions Regulation: A New Era Dawns Whether by the hands of Congress or the EPA, regulations on carbon emissions loom in the near future. Here's how U.S. industry is mobilizing.
The Motley Fool August 25, 2009 Brian Orelli	How to Keep From Losing Your Shirt More side effects for weight-loss drugs -- maybe.
Chemistry World September 15, 2014 Rebecca Trager	US bid to control power plant emissions challenged The governors of 15 US states have joined together to question the legality of the US Environmental Protection Agency's recently proposed climate rule to limit carbon emissions from the country's existing power plants.
Managed Care May 2004	Biologics Among Fastest Growers Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs.
Chemistry World April 7, 2014 Jessica Cocker	SERS tubing makes intravenous drug delivery safer A sensor that identifies drugs compounds and monitors changes in their concentrations as they enter the body through an intravenous drip could prevent medication mistakes.
Scientific American July 2007 Charles Q. Choi	Warming to Law After the U.S. Supreme Court ruling, how stiff will greenhouse gas regulations be?
Chemistry World July 1, 2013 Laura Howes	Aspen in $1 billion deal with Merck The deal involves 11 of Merck's drug brands and an active pharmaceutical ingredient business in the Netherlands.
Managed Care April 2001	Employers easing prescription limitations? Some older medications once viewed by employers as "lifestyle" drugs when making benefit decisions are slowly gaining recognition as important components of primary care...
The Motley Fool January 31, 2007 Brian Lawler	FDA Says Hurray for More Drug Safety The FDA outlines its proposal to increase drug safety. Whatever the FDA does, pharmaceutical investors should hope that its renewed interest in drug safety doesn't make the already lengthy process of bringing drugs to market any longer.
Knowledge@Wharton	Analyzing Brand-name and Generic Drug Costs in the U.S. and Eight Other Countries A new study comparing average prices for pharmaceuticals in nine countries -- the US, Canada, Chile, France, Germany, Italy, Japan, Mexico and the UK -- shows that average prices are highest in Japan, while prices in other countries are between 6% and 33% lower than prices in the US.
The Motley Fool May 19, 2007 Elizabeth Brokamp	Save Big on Prescriptions Tips for cutting medication costs.
The Motley Fool March 30, 2009 Brian Orelli	Change the Game? Change the Rules! There are ways for investors to get around Obama's plan to lower health care costs. Investing in drug companies in this time of "change" doesn't have to be scary. You've just got to find rule breaker-type drugmakers, because playing by the rules isn't going to cut it anymore.
Managed Care February 2008	Medication Payment Proposal Lets Consumers Pay Annually Researchers suggest an annual license fee that would entitle consumers to a year's worth of medication for each prescription they take to manage chronic diseases, with a very small or nonexistent copayment for each monthly supply.
IndustryWeek April 1, 2006 Jill Jusko	Manufacturers Achieve Emissions Goals Here is a short list of the many goals and achievements reached by manufacturers in their voluntary efforts to reduce greenhouse gas emissions. Carbon dioxide is a primary component of greenhouse gases.
Chemistry World May 25, 2010 Rebecca Trager	US scientific body seeks national climate change strategy The US National Research Council is urging its government to act immediately to reduce greenhouse gas emissions and develop a national strategy for adapting to the impacts of global warming.
The Motley Fool February 27, 2009 Brian Orelli	Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas.
The Motley Fool September 9, 2008 Brian Orelli	Drug Duo Combines Its Way Toward an Approval Bristol-Myers and AstraZeneca are trying to get their diabetes drug approved as a combination treatment.
The Motley Fool March 26, 2007 Rich Duprey	Acquisitions Mark Pharmaceutical Industry Japan's Eisai's newest acquisition continues the trend of pharmaceuticals buying up biotechs. Investors, take note.
Chemistry World December 2, 2011	European economy burdened by air pollution costs Europe is paying a high price for air pollution, according to a new report.
Geotimes April 2006 Naomi Lubick	Faith-Based Carbon Credit Systems Market-based approaches to help stem carbon releases, and in turn climate change, could prove difficult to marshal and enforce. Carbon credits and trade incentives are a small piece in a larger issue.
Investment Advisor July 2009 Robert F. Keane	How To Make Cap and Trade Work A successful market-based cap and trade program for carbon emissions requires a few minimum elements.
Fast Company November 2010 Rachel Arndt	The Challenges of Eco-Friendliness Starbucks isn't the only company discovering that setting sustainability targets is easy, but achieving them is not.
The Motley Fool December 12, 2007 Brian Lawler	Patent Bill Is No Panacea A new bill that was meant to strengthen the patent and other intellectual-property rights of drugmakers doesn't do enough to encourage pharma innovation.
Geotimes May 2007 Josh Trapani	A Political Comment on ... Proposals to Regulate Greenhouse Gas Emissions in the 110th Congress Establishing a nationwide market-based system for greenhouse gases may be one of the most difficult legislative steps for Congress to take, due largely to the potential environmental, economic and social consequences.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
The Motley Fool May 28, 2008 Brian Lawler	King Pays a Modest Ransom King Pharmaceuticals, a prolific acquirer of other companies' drugs, announces that it had painlessly staked its claim to yet another.
Reason April 2001 Ronald Bailey	Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry?
The Motley Fool April 26, 2011 Brian Orelli	There Is Only Downside in Consensus Hepatitis C advisory panels will almost certainly recommend approval. Almost.